AK
Amit Khurana
Dolat Capital
Track record
Building a track record
Graded calls
0 hit · 0 miss
Pending
2 awaiting resolution
By instrument
Graded calls broken down by what was being called.
Infosys
0 hit · 1 miss
0%
Sun Pharma
1 pending
Hindustan Unilever
1 pending
Recent calls
Newest first. Every call links back to its original source.
| Call | Instrument | Direction | Date | Verdict | Source |
|---|---|---|---|---|---|
| “Amit Khurana views Sun Pharma's recent acquisition as strategically sound and directionally correct for long-term growth…” | Sun Pharma | Bullish | 27 Apr 2026 | PENDING | Source |
| “Amit Khurana of Dolat Capital is positive on Hindustan Unilever (HUL) and the broader FMCG sector, particularly premium …” | Hindustan Unilever | Bullish | 19 Feb 2026 | PENDING | Source |
| “Amit Khurana of Dolat Capital expects the IT sector, including Infosys and TCS, to remain broadly range-bound in the int…” | Infosys | Neutral | 19 Feb 2026 | MISS | Source |
Not investment advice. Predict Future tracks what market analysts said in the press — every call links back to its original source. Hits and misses are shown factually, based on what was said and when, so you can judge a track record for yourself.